Description

Lacosamide (Racemate) CAS NO 175481-26-2 is a high-purity chemical intermediate and reference standard of significant importance in pharmaceutical research and development. This compound is the racemic mixture of the active pharmaceutical ingredient used in the treatment of epilepsy and neuropathic pain. It is primarily required by pharmaceutical manufacturers, contract research organizations (CROs), and academic institutions engaged in the synthesis of novel therapeutics, analytical method development, and pharmacokinetic studies.

Application

• Pharmaceutical Active Ingredient (API) Synthesis: Serves as a critical starting material or intermediate in the production of the enantiopure active pharmaceutical ingredient.
• Reference Standard for Analytical Development: Used for method validation, calibration, and quality control testing in HPLC, GC, and other chromatographic systems.
• Pharmacology and Preclinical Research: Employed in in-vitro and in-vivo studies to investigate mechanisms of action, efficacy, and safety profiles.
• Process Chemistry & Scale-Up: Utilized for developing and optimizing synthetic routes for commercial-scale manufacturing.
• Impurity Profiling and Identification: Acts as a key standard for identifying and quantifying related substances and degradation products.
• Regulatory Submission Support: Provides essential data and materials for regulatory filings (e.g., with FDA, EMA) for new drug applications.

Basic Information

Product Name	Lacosamide (Racemate)
CAS No.	175481-26-2
Molecular Formula	C13H18N2O3
Molecular Weight	250.29 g/mol
Synonyms	(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide (Racemate); (R,S)-Lacosamide; (RS)-2-Acetamido-N-benzyl-3-methoxypropionamide; Harkoseride; ADD 234037; SPM 927; Erlosamide; Vimpat (racemic form)
EINECS	Contact for details

Quality Control

Our Lacosamide (Racemate) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets stringent specifications for identity, purity, and impurity profiles, suitable for pharmaceutical R&D applications. Certificates of Analysis (COA) detailing results from tests such as HPLC assay, chiral purity, residual solvents, and heavy metals are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.5%
Chiral Purity (HPLC)	≤ 1.0% of any single enantiomer
Related Substances (HPLC)	Total impurities ≤ 1.5% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.